Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Chemotherapy + Immunotherapy Before Surgery for Pancreatic Cancer
Recruiting1 awardPhase 2
Houston, Texas
This trial is studying gemcitabine, nab-paclitaxel, durvalumab, and oleclumab to see how well they work in treating patients with resectable/borderline resectable primary pancreatic cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service